Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Resistant Hypertension: Insights on Evaluation and Management in the Post-SPRINT (Systolic Blood Pressure Intervention Trial) Era.
Townsend RR, Epstein M. Townsend RR, et al. Hypertension. 2016 Nov;68(5):1073-1080. doi: 10.1161/HYPERTENSIONAHA.116.07316. Epub 2016 Sep 6. Hypertension. 2016. PMID: 27600177 Review. No abstract available.
How can we effectively address the paraneoplastic dermatomyositis: Diagnosis, risk factors and treatment options.
Zerdes I, Tolia M, Nikolaou M, Tsoukalas N, Velentza L, Hajiioannou J, Mitsis M, Kyrgias G. Zerdes I, et al. J BUON. 2017 Jul-Aug;22(4):1073-1080. J BUON. 2017. PMID: 28952230 Free article.
METHODS: A systematic literature review was performed based on database search in PubMed/Medline and included English articles until December 2016. ...There is a higher risk of late toxicity in the presence of other concurrent vascular diseases, including diabetes, hype
METHODS: A systematic literature review was performed based on database search in PubMed/Medline and included English articles until Decembe …
The inhibitory effect of beta-lapachone on RANKL-induced osteoclastogenesis.
Gu DR, Lee JN, Oh GS, Kim HJ, Kim MS, Lee SH. Gu DR, et al. Biochem Biophys Res Commun. 2017 Jan 22;482(4):1073-1079. doi: 10.1016/j.bbrc.2016.11.160. Epub 2016 Nov 30. Biochem Biophys Res Commun. 2017. PMID: 27913299
The activation of NQO1 by β-L has beneficial effects on several metabolic syndromes, such as obesity, hypertension, and renal injury. ...Here, we show that β-L might be a potent inhibitor of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis. …
The activation of NQO1 by β-L has beneficial effects on several metabolic syndromes, such as obesity, hypertension, and renal injury. …
Feedback